These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 26429724)

  • 1. GNL3 and SKA3 are novel prostate cancer metastasis susceptibility genes.
    Lee M; Williams KA; Hu Y; Andreas J; Patel SJ; Zhang S; Crawford NP
    Clin Exp Metastasis; 2015 Dec; 32(8):769-82. PubMed ID: 26429724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.
    Winter JM; Curry NL; Gildea DM; Williams KA; Lee M; Hu Y; Crawford NPS
    BMC Genomics; 2018 Jun; 19(1):450. PubMed ID: 29890952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systems genetics approach identifies CXCL14, ITGAX, and LPCAT2 as novel aggressive prostate cancer susceptibility genes.
    Williams KA; Lee M; Hu Y; Andreas J; Patel SJ; Zhang S; Chines P; Elkahloun A; Chandrasekharappa S; Gutkind JS; Molinolo AA; Crawford NP
    PLoS Genet; 2014 Nov; 10(11):e1004809. PubMed ID: 25411967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germline genetic variation modulates tumor progression and metastasis in a mouse model of neuroendocrine prostate carcinoma.
    Patel SJ; Molinolo AA; Gutkind S; Crawford NP
    PLoS One; 2013; 8(4):e61848. PubMed ID: 23620793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping Complex Traits in a Diversity Outbred F1 Mouse Population Identifies Germline Modifiers of Metastasis in Human Prostate Cancer.
    Winter JM; Gildea DE; Andreas JP; Gatti DM; Williams KA; Lee M; Hu Y; Zhang S; ; Mullikin JC; Wolfsberg TG; McDonnell SK; Fogarty ZC; Larson MC; French AJ; Schaid DJ; Thibodeau SN; Churchill GA; Crawford NP
    Cell Syst; 2017 Jan; 4(1):31-45.e6. PubMed ID: 27916600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interspecies comparison of prostate cancer gene-expression profiles reveals genes associated with aggressive tumors.
    Kela I; Harmelin A; Waks T; Orr-Urtreger A; Domany E; Eshhar Z
    Prostate; 2009 Jul; 69(10):1034-44. PubMed ID: 19343735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Raf kinase inhibitor protein (RKIP) deficiency decreases latency of tumorigenesis and increases metastasis in a murine genetic model of prostate cancer.
    Escara-Wilke J; Keller JM; Ignatoski KM; Dai J; Shelley G; Mizokami A; Zhang J; Yeung ML; Yeung KC; Keller ET
    Prostate; 2015 Feb; 75(3):292-302. PubMed ID: 25327941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression profile of mouse prostate tumors reveals dysregulations in major biological processes and identifies potential murine targets for preclinical development of human prostate cancer therapy.
    Haram KM; Peltier HJ; Lu B; Bhasin M; Otu HH; Choy B; Regan M; Libermann TA; Latham GJ; Sanda MG; Arredouani MS
    Prostate; 2008 Oct; 68(14):1517-30. PubMed ID: 18668517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential metastasis-associated gene analysis of prostate carcinoma cells derived from primary tumor and spontaneous lymphatic metastasis in nude mice with orthotopic implantation of PC-3M cells.
    Chu JH; Sun ZY; Meng XL; Wu JH; He GL; Liu GM; Jiang XR
    Cancer Lett; 2006 Feb; 233(1):79-88. PubMed ID: 15885894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-Nucleotide Polymorphisms Sequencing Identifies Candidate Functional Variants at Prostate Cancer Risk Loci.
    Zhang P; Tillmans LS; Thibodeau SN; Wang L
    Genes (Basel); 2019 Jul; 10(7):. PubMed ID: 31323811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of a novel long non-coding RNA in 8q24 with prostate cancer susceptibility.
    Chung S; Nakagawa H; Uemura M; Piao L; Ashikawa K; Hosono N; Takata R; Akamatsu S; Kawaguchi T; Morizono T; Tsunoda T; Daigo Y; Matsuda K; Kamatani N; Nakamura Y; Kubo M
    Cancer Sci; 2011 Jan; 102(1):245-52. PubMed ID: 20874843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Candidate genes on murine chromosome 8 are associated with susceptibility to Staphylococcus aureus infection in mice and are involved with Staphylococcus aureus septicemia in humans.
    Yan Q; Ahn SH; Medie FM; Sharma-Kuinkel BK; Park LP; Scott WK; Deshmukh H; Tsalik EL; Cyr DD; Woods CW; Yu CA; Adams C; Qi R; Hansen B; Fowler VG
    PLoS One; 2017; 12(6):e0179033. PubMed ID: 28594911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of MyD88 leads to more aggressive TRAMP prostate cancer and influences tumor infiltrating lymphocytes.
    Peek EM; Song W; Zhang H; Huang J; Chin AI
    Prostate; 2015 Apr; 75(5):463-73. PubMed ID: 25597486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-invasive bioluminescent detection of prostate cancer growth and metastasis in a bigenic transgenic mouse model.
    Hsieh CL; Xie Z; Yu J; Martin WD; Datta MW; Wu GJ; Chung LW
    Prostate; 2007 May; 67(7):685-91. PubMed ID: 17342752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fine mapping and identification of candidate pulmonary adenoma susceptibility 1 genes using advanced intercross lines.
    Wang M; Lemon WJ; Liu G; Wang Y; Iraqi FA; Malkinson AM; You M
    Cancer Res; 2003 Jun; 63(12):3317-24. PubMed ID: 12810665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased levels of the FoxM1 transcription factor accelerate development and progression of prostate carcinomas in both TRAMP and LADY transgenic mice.
    Kalin TV; Wang IC; Ackerson TJ; Major ML; Detrisac CJ; Kalinichenko VV; Lyubimov A; Costa RH
    Cancer Res; 2006 Feb; 66(3):1712-20. PubMed ID: 16452231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in gene expression profiles during prostate cancer progression: functional correlations to tumorigenicity and down-regulation of selenoprotein-P in mouse and human tumors.
    Calvo A; Xiao N; Kang J; Best CJ; Leiva I; Emmert-Buck MR; Jorcyk C; Green JE
    Cancer Res; 2002 Sep; 62(18):5325-35. PubMed ID: 12235003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen-independent prostate cancer progression in the TRAMP model.
    Gingrich JR; Barrios RJ; Kattan MW; Nahm HS; Finegold MJ; Greenberg NM
    Cancer Res; 1997 Nov; 57(21):4687-91. PubMed ID: 9354422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relaxin promotes prostate cancer progression.
    Feng S; Agoulnik IU; Bogatcheva NV; Kamat AA; Kwabi-Addo B; Li R; Ayala G; Ittmann MM; Agoulnik AI
    Clin Cancer Res; 2007 Mar; 13(6):1695-702. PubMed ID: 17363522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic deletion of osteopontin in TRAMP mice skews prostate carcinogenesis from adenocarcinoma to aggressive human-like neuroendocrine cancers.
    Mauri G; Jachetti E; Comuzzi B; Dugo M; Arioli I; Miotti S; Sangaletti S; Di Carlo E; Tripodo C; Colombo MP
    Oncotarget; 2016 Jan; 7(4):3905-20. PubMed ID: 26700622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.